Chemours Q2 EPS $1.10 Beats $1.07 Estimate, Sales $1.64B Miss $1.69B Estimate
Portfolio Pulse from Benzinga Newsdesk
Chemours (NYSE:CC) reported Q2 earnings of $1.10 per share, beating the analyst consensus estimate of $1.07 by 2.8%. However, this is a 41.8% decrease from the same period last year. The company's quarterly sales were $1.64 billion, missing the analyst consensus estimate of $1.69 billion by 2.96%, and marking a 14.36% decrease from the same period last year.
July 28, 2023 | 5:02 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Chemours' Q2 earnings beat estimates but were lower than last year. Sales missed estimates and were also lower than last year.
Chemours' earnings beat estimates, which is positive. However, the decrease in earnings and sales compared to the same period last year, as well as the missed sales estimates, are negative factors that could impact the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100